Conversely, research by Cataldi et al. demonstrated that 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a common lipophilic substance used to induce PD reduces caveolin-1 expression, thus contributing to PD development [257]. This evidence concerns the gene CAV1 and Parkinson disease.